» Articles » PMID: 30506572

Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research

Overview
Publisher Wiley
Specialty Pharmacology
Date 2018 Dec 4
PMID 30506572
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The varying frequencies of pharmacogenetic alleles among populations have important implications for the impact of these alleles in different populations. Current population grouping methods to communicate these patterns are insufficient as they are inconsistent and fail to reflect the global distribution of genetic variability. To facilitate and standardize the reporting of variability in pharmacogenetic allele frequencies, we present seven geographically defined groups: American, Central/South Asian, East Asian, European, Near Eastern, Oceanian, and Sub-Saharan African, and two admixed groups: African American/Afro-Caribbean and Latino. These nine groups are defined by global autosomal genetic structure and based on data from large-scale sequencing initiatives. We recognize that broadly grouping global populations is an oversimplification of human diversity and does not capture complex social and cultural identity. However, these groups meet a key need in pharmacogenetics research by enabling consistent communication of the scale of variability in global allele frequencies and are now used by Pharmacogenomics Knowledgebase (PharmGKB).

Citing Articles

Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations.

Perez-Ramos L, Ibarra-Gomez L, Lubomirov R, Garcia-Cremades M, Asin-Prieto E, Fudio S Pharmaceutics. 2025; 16(12.

PMID: 39771527 PMC: 11728769. DOI: 10.3390/pharmaceutics16121548.


The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer Treatment.

Wu X, Xiong H Pharmaceutics. 2024; 16(11).

PMID: 39598531 PMC: 11597240. DOI: 10.3390/pharmaceutics16111407.


Decoding Pharmacogenomic Test Interpretation and Application to Patient Care.

Donnelly R, Cavallari L, McCune J, Trofe-Clark J, Formea C, Hoffecker G J Am Coll Clin Pharm. 2024; 7(6):581-588.

PMID: 39582510 PMC: 11583779. DOI: 10.1002/jac5.1958.


Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series.

Lorvellec M, Sipahimalani G, Lahutte B, Delacour H, Baldacci A, Saguin E Front Pharmacol. 2024; 15:1440523.

PMID: 39444600 PMC: 11496244. DOI: 10.3389/fphar.2024.1440523.


Genetic ancestry in population pharmacogenomics unravels distinct geographical patterns related to drug toxicity.

Karamperis K, Katz S, Melograna F, Ganau F, Van Steen K, Patrinos G iScience. 2024; 27(10):110916.

PMID: 39391720 PMC: 11465127. DOI: 10.1016/j.isci.2024.110916.


References
1.
Maples B, Gravel S, Kenny E, Bustamante C . RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am J Hum Genet. 2013; 93(2):278-88. PMC: 3738819. DOI: 10.1016/j.ajhg.2013.06.020. View

2.
Bustamante C, Burchard E, De La Vega F . Genomics for the world. Nature. 2011; 475(7355):163-5. PMC: 3708540. DOI: 10.1038/475163a. View

3.
Rahsaz M, Azarpira N, Nikeghbalian S, Aghdaie M, Geramizadeh B, Moini M . Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population. Exp Clin Transplant. 2012; 10(1):24-9. DOI: 10.6002/ect.2011.0093. View

4.
Burchard E, Ziv E, Coyle N, Gomez S, Tang H, Karter A . The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003; 348(12):1170-5. DOI: 10.1056/NEJMsb025007. View

5.
Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View